Pacific Biosciences of California Inc said on Wednesday SoftBank Group Corp will invest $900 million in the gene-sequencing firm, sending its shares up 21% before the bell.
The latest healthcare investment from SoftBank, in the form of convertible debt, will help accelerate the commercialization of Pacific Biosciences’ gene sequencing technology.
